Stable Angina
📧 Sign up to get email alerts when something new happens for Stable Angina.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-05-04FDA Approved: AMLODIPINE BESYLATE — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories, LLC's original application for amlodipine besylate, a generic version, for indications including hypertens…
-
CLINICAL_TRIALS trial_result · 2009-01-22Clinical Trial Update: The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases [Phase 2, Phase 3]
This completed Phase 2/3 trial investigates the efficacy of influenza vaccination in patients with coronary artery disease, including those …
-
CLINICAL_TRIALS trial_result · 2009-01-22Clinical Trial Update: The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases [Phase 2, Phase 3]
A completed Phase 2/Phase 3 clinical trial evaluating whether influenza vaccination reduces cardiovascular events in patients with coronary …
-
CLINICAL_TRIALS research · 2008-11-06Clinical Trial Update: Safety and Efficacy of Intracoronary Ad5FGF-4 in Patients With Stable Angina [Phase 2, Phase 3]
This clinical trial update concerns the safety and efficacy of intracoronary Ad5FGF-4 in patients with stable angina across Phase 2 and Phas…
-
CLINICAL_TRIALS trial_result · 2008-07-22Clinical Trial Update: Diagnostic Value of HS-CRP in Stable Angina. [NA]
This completed trial evaluated whether high-sensitivity C-reactive protein (HS-CRP) has diagnostic value in patients with stable angina and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-07-17FDA Approved: DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for Diltiazem Hydrochloride Extended-Release from Endo USA, Inc., resulting in an approved update to…
-
FDA approval · 2007-07-17FDA Approved: AMLODIPINE BESYLATE — Original Application (Aurobindo Pharma Limited)
FDA approves Aurobindo Pharma's amlodipine besylate as a generic product. It is indicated for hypertension and various forms of angina.
-
FDA approval · 2007-07-11FDA Approved: AMLODIPINE BESYLATE — Original Application (ACI Healthcare USA, Inc.)
FDA approved the original application for amlodipine besylate from ACI Healthcare USA, Inc., approving a generic version of this antihyperte…
-
FDA approval · 2007-06-28FDA Approved: AMLODIPINE BESYLATE — Original Application (Teva Pharmaceuticals, Inc.)
The FDA approved Teva Pharmaceuticals' amlodipine besylate as a generic product in an Original Application for indications including hyperte…
-
FDA approval · 2007-05-11FDA Approved: CARTIA XT — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for CARTIA XT (diltiazem hydrochloride) from Actavis Pharma, Inc.
-
FDA approval · 2007-04-27FDA Approved: CARDIZEM LA — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for Cardizem LA (diltiazem hydrochloride extended-release) from Bausch Health US LLC.
-
CLINICAL_TRIALS trial_result · 2007-03-14Clinical Trial Update: RRISC Study: Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent. [Phase 2]
A Phase 2 clinical trial (RRISC) evaluating the Cypher sirolimus-eluting stent to reduce restenosis in saphenous vein grafts has completed.
-
CLINICAL_TRIALS research · 2006-10-20Clinical Trial Update: EPC by Intracoronary Injection in Patients With Chronic Stable Angina [Phase 2]
Phase 2 clinical trial update of intracoronary endothelial progenitor cell therapy for chronic stable angina due to coronary artery disease;…
-
CLINICAL_TRIALS research · 2006-07-11Clinical Trial Update: A Clinical Trial of a Self-Management Education Program for People With Chronic Stable Angina [Phase 1]
A Phase 1 clinical trial is evaluating a self-management education program for people with chronic stable angina.